


Phase 2 Study Shows Promising Results for Deucravacitinib in PsA

Spine School: Axial Manifestations of Psoriatic Arthritis

European Medicines Agency Committee Issues Positive Opinion for Secukinumab in Pediatric Arthritic Disease

Medication Preferences & Current Practices for PsA

FDA Approves Risankizumab-rzaa for PsA

Pregnancy Outcomes in Patients with Psoriatic Arthritis

New Data Highlight Effectiveness of Guselkumab for Patients with PsA
